VC firms
Achieving global impact in effective healthcare & sustainable agriculture by helping talented entrepreneurs / scientist set up exceptional companies.
Overview
Investment Type
Venture Capital
Investment Stage
Series B
Funds raised 1
| Date | Fund size | Announcement |
| Sign up to see | Sign up to see | Sign up to see |
Portfolio 20
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Oct 12, 2022 | SibyllaBiotech | sibyllabiotech.it | $23M | Italy, Veneto, Verona |
| Aug 31, 2022 | AstriVax | astrivax.com | $32.62M | Belgium, Flemish Brabant, Heverlee |
| Jun 6, 2022 | Dualyx | dualyx.com | $43.75M | |
| Dec 31, 2021 | Corteria Pharmaceuticals | corteriapharma.com | $69.6M | France, Ile-of-France, Paris |
| Mar 10, 2021 | Agomab Therapeutics | agomab.com | $401.25M | Belgium, East Flanders, Ghent |
| Coave Therapeutics | coavetx.com | $71.83M | France, Ile-de-France | |
| Confo Therapeutics | confotherapeutics.com | $106.07M | Belgium | |
| Oxular | oxular.com | $37M | United Kingdom, England, Oxford | |
| Animab | animab.com | $11.76M |
Show more
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 10, 2025 | Exclusive: RootWave bags $15m to expand its chemical-free weeding platform to Europe, US | UK-based RootWave has raised $15 million for its high-frequency electrical weed control technology. Food and ag VC Clay Capital led the round with participation from Boerenbond Group investment arm Agri Investment Fund, agtech and wine tech... |
| Sep 25, 2024 | Tanai Therapeutics secures additional financing from Novo Nordisk and BioGeneration Ventures for novel obesity drug | Ghent, Belgium, 19 September 2024 – Tanai Therapeutics (“the Company” or “Tanai”), a VIB spin-off company developing a new therapeutic class of obesity treatments, today announces it has secured additional financing from Novo Nordisk A/S an... |
| Jul 10, 2024 | Augustine Therapeutics: €17 Million Raised For Developing Neurodegenerative And Cardiometabolic Disease Treatments | Augustine Therapeutics, a pioneering biotech company focused on novel treatments for neurodegenerative and cardiometabolic diseases, announced that it has raised €17 million in the first closing of its Series A round. This funding round was... |
| May 27, 2024 | French biotech startup Biodol Therapeutics secures €7M to treat chronic pain: Know more | Read this article in: Montarnaud-based Biodol Therapeutics, a French biotech company developing next-generation pain treatments, announced on Tuesday, May 21, that it has been awarded €7M by BPI France through the i-DEMO call for projects. ... |
| Apr 25, 2024 | Dutch-based Flindr Therapeutics secures €20M to discover and develop precision oncology therapeutics | Read this article in: Netherlands-based Flindr Therapeutics, a company focused on precision cancer treatments, announced that it has secured €20M in a Series A round of funding. This funding will help advance the Dutch company’s cancer trea... |
| Dec 6, 2023 | Tanai Therapeutics raises € 2.85 million round in Seed funding | Ghent, 6 December 2023 – VIB, Flanders’ leading life sciences institute, together with lead investor V-Bio Ventures has launched a new spin-off company based on research at the VIB-UGent Center for Inflammation Research. With an initial see... |
| Aug 16, 2023 | ‘Boil the weed inside out’: RootWave launches high-frequency, ‘regen ag-friendly’ weed zapper for orchards | Growers may differ on their methods of weed management, but most would agree outsmarting those weeds is one of the toughest tasks in the business for organic farmers and conventional row croppers alike. Chemicals such as Glyphosate were sup... |
| Apr 1, 2022 | V-Bio Ventures Closes Second Fund, at EUR 110M | V-Bio Team V-Bio Ventures, a Ghent, Belgium-based independent venture capital firm focused on biotech, closed its second fund, V-Bio Fund 2, at EUR 110m. Almost all limited partners of their first fund are participating in this second fund,... |
| Nov 24, 2020 | With companies like Aphea Bio & Biotalys, Ghent is Europe’s hidden gem for ag biotech | The Belgian city of Ghent owes its medieval splendor to being in the middle of the sheep-filled pastureland of Flanders. In centuries past, this provided plentiful supplies of wool – just as breakthrough textiles technologies took off acros... |
Show more
Reviews 0
FAQ about V-Bio Ventures
What funds has V-Bio Ventures raised?
V-Bio Ventures has announced 1 fund on Parsers VC.
How many startups has V-Bio Ventures invested in?
V-Bio Ventures has 20 portfolio companies on Parsers VC, among them SibyllaBiotech, AstriVax and Dualyx.
What has the press written about V-Bio Ventures?
Parsers VC has collected 11 articles mentioning V-Bio Ventures, among them “Exclusive: RootWave bags $15m to expand its chemical-free weeding platform to Europe, US” (Jun 10, 2025) and “Tanai Therapeutics secures additional financing from Novo Nordisk and BioGeneration Ventures for novel obesity drug” (Sep 25, 2024).
Is V-Bio Ventures still active?
Yes, V-Bio Ventures is active; its latest activity on Parsers VC dates from Dec 18, 2025.